Works matching IS 09697128 AND DT 2006 AND VI 13 AND IP 21

Results: 8

Topical antiviral siRNA: A practical siRNA microbicide?

Published in:

Gene Therapy, 2006, v. 13, n. 21, p. 1493, doi. 10.1038/sj.gt.3302764

By:

Rossi, J. J.

Publication type:

Article

A multifunctional PEI-based cationic polyplex for enhanced systemic p53-mediated gene therapy.

Published in:

Gene Therapy, 2006, v. 13, n. 21, p. 1512, doi. 10.1038/sj.gt.3302773

By:

Moffatt, S.;
Wiehle, S.;
Cristiano, R. J.

Publication type:

Article

AAV Serotype-1 mediates early onset of gene expression in mouse hearts and results in better therapeutic effect.

Published in:

Gene Therapy, 2006, v. 13, n. 21, p. 1495, doi. 10.1038/sj.gt.3302787

By:

Su, H.;
Huang, Y.;
Takagawa, J.;
Barcena, A.;
Arakawa-Hoyt, J.;
Ye, J.;
Grossman, W.;
Kan, Y. W.

Publication type:

Article

Using magnetic forces to enhance non-viral gene transfer to airway epithelium in vivo.

Published in:

Gene Therapy, 2006, v. 13, n. 21, p. 1545, doi. 10.1038/sj.gt.3302803

By:

Xenariou, S.;
Griesenbach, U.;
Ferrari, S.;
P.Dean;
Scheule, R. K.;
Cheng, S. H.;
Geddes, D. M.;
Plank, C.;
Alton, E. W. F. W

Publication type:

Article

Synergy between expression of fusogenic membrane proteins, chemotherapy and facultative virotherapy in colorectal cancer.

Published in:

Gene Therapy, 2006, v. 13, n. 21, p. 1534, doi. 10.1038/sj.gt.3302806

By:

Hoffmann, D.;
Bangen, J.-M.;
Bayer, W.;
Wildner, O

Publication type:

Article

Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectors.

Published in:

Gene Therapy, 2006, v. 13, n. 21, p. 1524, doi. 10.1038/sj.gt.3302807

By:

Schambach, A.;
Mueller, D.;
Galla, M.;
Verstegen, M. M. A.;
Wagemaker, G.;
Loew, R.;
Baum, C.;
Bohne, J

Publication type:

Article

Construction of folate-conjugated pRNA of bacteriophage phi29 DNA packaging motor for delivery of chimeric siRNA to nasopharyngeal carcinoma cells.

Published in:

2006

By:

Guo, S.;
Huang, F.;
Guo, P.

Publication type:

Correction Notice

Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF<sub>121</sub> (AdVEGF121) versus maximum medical treatment.

Published in:

Gene Therapy, 2006, v. 13, n. 21, p. 1503, doi. 10.1038/sj.gt.3302802

By:

Stewart, D. J.;
Hilton, J. D.;
Arnold, J. M. O.;
Gregoire, J.;
Rivard, A.;
Archer, S. L.;
Charbonneau, F.;
Cohen, E.;
Curtis, M.;
Buller, C. E.;
Mendelsohn, F. O.;
Dib, N.;
Page, P.;
Ducas, J.;
Plante, S.;
Sullivan, J.;
Macko, J.;
Rasmussen, C.;
Kessler, P. D.;
Rasmussen, H. S.

Publication type:

Article